BackgroundCalcaneal apophysitis is a common clinical entity affecting children and adolescents. It is also known as Sever’s disease. Heel pain without a recent trauma is the primary manifestation. There are limited studies on the incidence of this disease. In this study, we aimed to report the regional incidence in Istanbul.MethodsThis retrospective audit of health records of all paediatric patients aged 6–17 years between January 1, 2014, and December 15, 2017 was undertaken. During this period, data were extracted from health records that recorded calcaneal apophysitis as the primary diagnosis.ResultsThe 4-year incidence of calcaneal apophysitis was found to be 0.35% (74 of 20,967 paediatric patients). It commonly affected males, and bilateral cases were more common than unilateral cases. There were more admissions during the spring season, which may indicate a possible association with physical activity.ConclusionAlthough calcaneal apophysitis is a relatively common paediatric foot problem, due to its benign course and spontaneous healing capacity, most physicians are not interested in this topic. However, increased awareness of this diagnosis is important for reducing the rates of unnecessary radiological examinations and orthopaedic referrals. With increased knowledge, most cases may be diagnosed at the family physician level, which may decrease the economic burden on the health system. Incidence reports from various countries and regions may be published in the future.
Aim: De Quervain's disease, which is known as tenosynovitis of the first radial dorsal compartment, usually is a self-limiting condition and it could be managed conservatively. In this study, we aimed to evaluate the factors affecting the success of the conservative treatment. Methods: Patients who admitted to outpatient service with radial styloid pain and diagnosed as de Quervain's disease between March 2014 and December 2016 were enrolled to our study. A total number of 84 patients evaluated retrospectively, and 12 of them excluded due to inadequate patient information, previous interventions in other clinics, and lost to follow up. Patients' files with regard to the patients' data on age, sex, duration of symptomatic period, history of previous trauma, season of admission and need of surgery were evaluated. Results: Mean age of the patients was 42.24 (range 16-66) years. Of the cohort, 58 patients (80.6%) were female and the remaining patients (19.4%) were male. Mean length of pre-admission symptomatic period was 2.2 (range 1-12) months. There was no significant correlation between the resistance to treatment and the duration of the symptoms (r=0.4597). Sixty-one of 72 patients (84.7%) received one month of orthosis and oral/local medication and they were all healed. The remaining 11 patients with persistent pain received additional steroid injections. The mean age was 46.72 years at the injection group, and 10 of these 11 were female. Two female patients from these 11 resistant cases underwent surgical decompression. Conclusion: In conclusion, our study also supported the self-limiting clinical feature of de Quervain's disease. Most of the patients have satisfactory results with conservative treatment or corticosteroid injections if needed. Most of the patients who needed corticosteroid injections in addition to splint use were female; therefore, the female patients should be informed in this aspect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.